Basic Study
Copyright ©The Author(s) 2018.
World J Crit Care Med. Feb 4, 2018; 7(1): 1-8
Published online Feb 4, 2018. doi: 10.5492/wjccm.v7.i1.1
Figure 1
Figure 1 Kaplan–Meier survival analysis. The survival rates 8 h after recovery from HS were 71%, 94%, and 82% in the control group, SPL group, and EP group, respectively. There were no significant differences in survival rate among the three groups (P = 0.219). HS: Hemorrhagic shock; EP: Eplerenone; SPL: Spironolactone.